abstract |
Modified factor VII polypeptides and uses thereof are provided. Such modified FVII polypeptides include Factor VIIa and other forms of Factor VII. Among the modified FVII polypeptides are provided those with altered procoagulant activity, including altered activity, typically increased procoagulant activity. Accordingly, such modified polypeptides are therapeutic agents. |